Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: A multicenter study of 412 patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 45

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

356

HTML

3200

Figures (1-3)

253

Tables (1-3)

237

Sum=4046

Dec 7, 2006 (publication date) through Jan 29, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 7, 2006; 12(45): 7319-7325
Published online Dec 7, 2006. doi: 10.3748/wjg.v12.i45.7319

Table 3 Factors associated with recurrence-free survival (Multivariate analysis)

	Relative risk	95% CI	P
Use of anti-lymphocyte antibodies	1.8	1.2-2.6	0.005
Tumor differentiation	1.6	1.24-2.06	0.0006
Maximum diameter of the largest nodule	1.12	1.08-1.17	< 0.0001
Portal/hepatic vein obstruction	1.6	1.01-2.72	0.06
Number of nodules	1.13	1-1.28	0.06
Recent period of transplantation	0.66	0.54-0.82	0.0001

Citation: Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Compagnon P, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouillères O, Cherqui D, Duvoux C. Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: A multicenter study of 412 patients. World J Gastroenterol 2006; 12(45): 7319-7325
URL: https://www.wjgnet.com/1007-9327/full/v12/i45/7319.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i45.7319